European Union (EU) drug regulator is set to make a decision on the BioNTech-Pfizer vaccine, amid political pressure from Berlin. Germany is on the verge of beginning vaccinations before the new year.
The European Union is on track to approve its first COVID-19 vaccine ahead of Christmas. Amid political pressure, the Amsterdam-based European Medicines Agency (EMA) has moved up the expert panel review meeting on the BioNTech-Pfizer vaccine to December 21, eight days sooner than its original deadline of December 29.
“This is good news for the European Union,” said German Health Minister Jens Spahn. “The goal is to achieve European vaccine approval before Christmas and to start vaccinating people in Germany before the turn of the year.”